The effect of low dose intra-articular S(+) ketamine on osteoarthritis in rats: an experimental study.
Eugênio Dos Santos Neto, Pedro Paulo de Alcantara Pedro, Maria do Socorro de Sousa Cartágenes, José Osvaldo Barbosa Neto, João Batista Santos Garcia
Brazilian journal of anesthesiology (Elsevier) January 1, 2024 DOI: 10.1016/j.bjane.2024.844502 (opens in new tab) via PubMed
Summary
AI-generated from the abstractIn a rat model of osteoarthritis, low doses of S(+)-ketamine reduced pain behaviors such as allodynia and hyperalgesia for up to 28 days and improved weight distribution and walking, but did not reduce synovial inflammation or reverse histopathological changes in the joint lining.
Study at a glance
| Characteristics | Preclinical study Peer reviewed |
|---|---|
| Sample size | 72 |
| Population | Rats with induced osteoarthritis |
| Intervention | S(+)-ketamine |
| Dose | 0.5 mg.kg-1 |
| Duration | 28 days |
| Keywords | Animal models S+-ketamine Synovial membrane Synovitis Pain-management |
| Citations | 1 |
| Key finding | S(+)-ketamine reduced pain behaviors but did not diminish synovial inflammation in an osteoarthritis rat model. |
Abstract
This study aimed to investigate the analgesic impact of S(+)-ketamine on pain behavior and synovial inflammation in an osteoarthritis (OA) model. Animals were grouped as follows: OA-Saline (n = 24) and OA-Ketamine (n = 24), OA induced via intra-articular sodium monoiodoacetate (MIA); a Non-OA group (n = 24) served as the control. On the 7th day post OA induction, animals received either saline or S(+)-ketamine (0.5 mg.kg-1). Behavioral and histopathological assessments were conducted up to day 28. S(+)-ketamine reduced allodynia from day 7 to 28 and hyperalgesia from day 10 to 28. It notably alleviated weight distribution deficits from day 10 until the end of the study. Significant walking improvement was observed on day 14 in S(+)-ketamine-treated rats. Starting on day 14, OA groups showed grip force decline, which was countered by S(+)-ketamine on day 21. However, S(+)-ketamine did not diminish synovial inflammation. Low Intra-articular (IA) doses of S(+)-ketamine reduced MIA-induced OA pain but did not reverse synovial histopathological changes. 23115 012030/2009-05.